Company Filing History:
2 out of 10 
2 out of 4 Years Active: 2023-2025
Title: Helena Verdaguer: Innovator in Cancer Biomarkers
Introduction
Helena Verdaguer is a prominent inventor based in Barcelona, Spain. She has made significant contributions to the field of cancer research, particularly in the area of biomarkers. With a total of 2 patents, her work focuses on improving cancer detection and treatment.
Latest Patents
One of her latest patents is titled "PD-ECGF as biomarker of cancer." This invention is related to predicting cancer detection, diagnosis, monitoring, and predicting response to treatment. Specifically, it involves the use of platelet-derived endothelial cell growth factor (PD-ECGF) levels as a potential value in monitoring disease evolution and predicting response to anti-angiogenic treatment. This innovative approach aims to enhance the accuracy of cancer diagnostics and treatment strategies.
Career Highlights
Helena has worked with notable institutions such as the Institut Català d'Oncologia (ICO) and the Fundació Institut d'Investigació Biomèdica de Bellvitge (IDIBELL). Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of her coworkers include Oriol Casanovas Casanovas and Gabriela Jiménez Valerio. Their collaborative efforts have further advanced the research and development of cancer biomarkers.
Conclusion
Helena Verdaguer's innovative work in cancer biomarkers exemplifies her commitment to improving cancer detection and treatment. Her contributions are paving the way for advancements in medical research and patient care.